Latest Mergers And Acquisitions News

UNITH Ltd reports a 9.3% rise in Q3 FY25 cash receipts driven by its B2C subscription surge and a landmark pharmaceutical contract, alongside strategic platform upgrades and leadership changes.

Enlitic reported a 5.8% revenue increase in Q1 CY25, strengthened its collaboration with GE HealthCare, and accelerated integration of Laitek, positioning itself for operational cashflow break-even by the end of 2025.

Lithium Plus Minerals Limited (ASX: LPM) reported significant progress on its Lei Lithium Development with advancing environmental approvals and infrastructure design, while its Wingate Project reveals promising large-scale gold potential. The company maintains a solid cash position of AUD 3.6 million as it prepares for upcoming exploration campaigns.

Cadoux Limited has made significant progress in its High Purity Alumina and Minhub rare earth projects during Q1 2025, advancing engineering studies, securing key contracts, and strengthening ESG initiatives while preparing for commercialisation.

D3 Energy’s latest quarterly report reveals a promising new helium production province at its ER315 permit, alongside expanded exploration permits and preparations for a key Production Right application.

Santos Limited’s 2024 Annual Report reveals a 5% decline in production and a 9% drop in sales revenue, yet highlights significant progress in carbon capture and storage projects and emissions reduction targets.

Renegade Exploration reports significant discoveries of critical defence metals germanium and gallium at its Yukon Andrew Deposit, alongside promising gold-silver prospects, while progressing copper and cobalt projects in Queensland amid a tight cash position.

CAQ Holdings Limited posted a 5% decline in leasing revenue for the March 2025 quarter, while vacancy rates held steady and operating cash flow remained positive despite ongoing regulatory uncertainties in China.

Zenith Minerals reported a pivotal quarter advancing exploration at its Dulcie Far North and Red Mountain gold projects, while agreeing to divest its Turkish Kavaklitepe interest, sharpening its focus on domestic assets.

EVE Health Group has executed a binding agreement to acquire Australian biotech Nextract, targeting rapid-onset treatments in the $16 billion global erectile dysfunction and dysmenorrhea markets. The acquisition, supported by a $1.5 million capital raise and share consolidation, marks a strategic shift into regulated pharmaceutical channels.

Activeport Group Ltd reported a robust 49.3% increase in software revenue for Q3 2025, driven by strategic wins across Asia and Australia, even as SaaS revenue declined due to restructuring. The company’s new technology deployments and cost-cutting measures position it for growth in the coming quarters.

DGR Global Limited reported steady progress in project generation and strategic investments during Q1 2025, while navigating ongoing legal challenges and securing a $23.5 million funding facility to support operations and refinancing.